{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:09:02Z","timestamp":1782882542748,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015689","name":"Institut Teknologi Bandung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020473","name":"Ministry of Research Technology and Higher Education of the Republic of Indonesia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021834","name":"Research Institute for Microbial Diseases, Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijbiomac.2025.144412","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:41:05Z","timestamp":1747741265000},"page":"144412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Construction of a variable fragment (Fv)-immunoglobulin A (IgA) anti-receptor binding domain (RBD) SARS-CoV-2 library based on IgA from Indonesian COVID-19 survivors"],"prefix":"10.1016","volume":"315","author":[{"given":"Adam","family":"Darsono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernawati Arifin","family":"Giri-Rachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluicia Anita","family":"Artarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Virya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Lusiany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dessy","family":"Natalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Gita","family":"Naully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendra","family":"Saputra Ismanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dita","family":"Pratama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ihsanawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marselina Irasonia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144412_bb0005","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144412_bb0010","article-title":"SARS-CoV-2 omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents","volume":"3","author":"Garcia-Valtanen","year":"2022","journal-title":"Cell Rep. Med."},{"issue":"7923","key":"10.1016\/j.ijbiomac.2025.144412_bb0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144412_bb0020","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41467-024-45274-3","article-title":"Virological characteristics of the SARS-CoV-2 omicron XBB.1.5 variant","volume":"15","author":"Tamura","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144412_bb0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/vaccines12020144","article-title":"Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4\/5 bivalent booster","volume":"12","author":"Machado","year":"2024","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144412_bb0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144412_bb0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.chembiol.2024.03.008","article-title":"SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs","volume":"31","author":"Iketani","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144412_bb0040","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/S1473-3099(22)00311-5","article-title":"Monoclonal antibody therapies against SARS-CoV-2","volume":"22","author":"Focosi","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.144412_bb0045","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/acs.jpcb.2c00708","article-title":"Cocktail of REGN antibodies binds more strongly to SARS-CoV-2 than its components, but the omicron variant reduces its neutralizing ability","volume":"126","author":"Nguyen","year":"2022","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144412_bb0050","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.ymthe.2022.02.013","article-title":"Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy","volume":"30","author":"Minenkova","year":"2022","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144412_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284173","article-title":"Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants","volume":"18","author":"Boonkrai","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0060","doi-asserted-by":"crossref","unstructured":"A. Zhang, H.D. Stacey, M.R. D'Agostino, Y. Tugg, A. Marzok, M.S. Miller. Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. Nat. Rev. Immunol. 23(6) 381\u2013396. doi:https:\/\/doi.org\/10.1038\/s41577-022-00813-1.","DOI":"10.1038\/s41577-022-00813-1"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144412_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tips.2022.12.005","article-title":"Computational and artificial intelligence-based methods for antibody development","volume":"44","author":"Kim","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"7807","key":"10.1016\/j.ijbiomac.2025.144412_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144412_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144412_bb0080","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2020.06.044","article-title":"Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients","volume":"182","author":"Kreer","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144412_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chom.2021.12.010","article-title":"Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers","volume":"30","author":"Vanshylla","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144412_bb0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2022.03.019","article-title":"A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2","volume":"55","author":"Wang","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144412_bb0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nbt.2782","article-title":"The promise and challenge of high-throughput sequencing of the antibody repertoire","volume":"32","author":"Georgiou","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144412_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrmicro3415","article-title":"Pathogen manipulation of B cells: the best defence is a good offence","volume":"13","author":"Nothelfer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144412_bb0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4161\/mabs.3.4.16092","article-title":"Immunoglobulin A: A next generation of therapeutic antibodies?","volume":"3","author":"Bakema","year":"2011","journal-title":"mAbs"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.144412_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000510251","article-title":"When therapeutic IgA antibodies might come of age","volume":"106","author":"Sterlin","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/immuno2040036","article-title":"Harnessing nasal immunity with IgA to prevent respiratory infections","volume":"2","author":"Joseph","year":"2022","journal-title":"Immuno"},{"issue":"577","key":"10.1016\/j.ijbiomac.2025.144412_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144412_bb0125","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/bib\/bbz095","article-title":"Computational approaches to therapeutic antibody design: established methods and emerging trends","volume":"21","author":"Norman","year":"2020","journal-title":"Brief. Bioinform."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144412_bb0130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4049\/immunohorizons.2300102","article-title":"Recent advances in the development of monoclonal antibodies and next-generation antibodies","volume":"7","author":"Singh","year":"2023","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-7180-0_3","article-title":"Isolation of antibodies from human plasma, saliva, breast Milk, and gastrointestinal fluid","volume":"1643","author":"Schneider","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100443","article-title":"Immunogenicity studies of recombinant RBD SARS-CoV-2 as a COVID-19 vaccine candidate produced in Escherichia coli","volume":"16","author":"Safitri","year":"2024","journal-title":"Vaccine X"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144412_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/1348-0421.12874","article-title":"Deneddylation by SENP8 restricts hepatitis B virus propagation","volume":"65","author":"Chen","year":"2021","journal-title":"Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144412_bb0150","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bioinformatics\/btv552","article-title":"ANARCI: antigen receptor numbering and receptor classification","volume":"32","author":"Dunbar","year":"2016","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144412_bb0155","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/pro.3633","article-title":"AbRSA: A robust tool for antibody numbering","volume":"28","author":"Li","year":"2019","journal-title":"Protein Sci."},{"issue":"577","key":"10.1016\/j.ijbiomac.2025.144412_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144412_bb0165","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein-protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144412_bb0170","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42003-023-04927-7","article-title":"ImmuneBuilder: deep-learning models for predicting the structures of immune proteins","volume":"6","author":"Abanades","year":"2023","journal-title":"Commun Biol"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144412_bb0175","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.1810576116","article-title":"Five computational developability guidelines for therapeutic antibody profiling","volume":"116","author":"Raybould","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0180","first-page":"1","article-title":"Information-driven antibody\u2013antigen modelling with HADDOCK","volume":"2552","author":"Ambrosetti","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144412_bb0185","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/prot.26018","article-title":"PDB-tools web: A user-friendly interface for the manipulation of PDB files","volume":"89","author":"Jim\u00e9nez-Garc\u00eda","year":"2021","journal-title":"Proteins"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144412_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4473","article-title":"PDBsum1: a standalone program for generating PDBsum analyses","volume":"31","author":"Laskowski","year":"2022","journal-title":"Protein Sci."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.144412_bb0195","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: a web server for predicting the binding affinity of protein-protein complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.144412_bb0200","doi-asserted-by":"crossref","first-page":"W276","DOI":"10.1093\/nar\/gkac240","article-title":"Search and sequence analysis tools services from EMBL-EBI in 2022","volume":"50","author":"Madeira","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"Web Server issue","key":"10.1016\/j.ijbiomac.2025.144412_bb0205","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkn201","article-title":"Ncbi blast: a better web interface","volume":"36","author":"Johnson","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.603996","article-title":"Evaluating SARS-CoV-2 seroconversion following relieve of confinement measures","volume":"7","author":"Gon\u00e7alves","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0215","author":"Villa"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144412_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.immuni.2022.12.005","article-title":"Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies","volume":"56","author":"Pushparaj","year":"2023","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144412_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109604","article-title":"Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals","volume":"36","author":"Chen","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144412_bb0230","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1038\/s41467-021-24123-7","article-title":"Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144412_bb0235","first-page":"705","article-title":"Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple omicron subvariants","volume":"3","author":"Duty","year":"2022","journal-title":"Med (N. Y.)."},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0240","article-title":"Discovery and characterization of SARS-CoV-2 reactive and neutralizing antibodies from humanized CAMouseHG mice through rapid Hybridoma screening and high-throughput single-cell V(D)J sequencing","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144412_bb0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41421-021-00295-w","article-title":"Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries","volume":"7","author":"Pan","year":"2021","journal-title":"Cell Discov."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144412_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109433","article-title":"A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD Interface and is tolerant to Most known RBD mutations","volume":"36","author":"Bertoglio","year":"2021","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144412_bb0255","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/19420862.2016.1205773","article-title":"ABodyBuilder: automated antibody structure prediction with data-driven accuracy estimation","volume":"8","author":"Leem","year":"2016","journal-title":"mAbs"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144412_bb0260","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jmb.2005.05.066","article-title":"The limit of accuracy of protein modeling: influence of crystal packing on protein structure","volume":"351","author":"Eyal","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102379","article-title":"Advances in computational structure-based antibody design","volume":"74","author":"Hummer","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144412_bb0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/1547691X.2013.821564","article-title":"Immunogenicity of therapeutic proteins: influence of aggregation","volume":"11","author":"Ratanji","year":"2014","journal-title":"J. Immunotoxicol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144412_bb0275","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.tibtech.2014.05.005","article-title":"Therapeutic protein aggregation: mechanisms, design, and control","volume":"32","author":"Roberts","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.782506","article-title":"In silico analyses on the comparative potential of therapeutic human monoclonal antibodies against newly emerged SARS-CoV-2 variants bearing mutant spike protein","volume":"12","author":"Das","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.144412_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2023.1172027","article-title":"Predicting changes in neutralizing antibody activity for SARS-CoV-2 XBB.1.5 using in silico protein modeling","volume":"3","author":"Ford","year":"2023","journal-title":"Front. Virol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025049645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025049645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:03:37Z","timestamp":1782878617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025049645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":57,"alternative-id":["S0141813025049645"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144412","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of a variable fragment (Fv)-immunoglobulin A (IgA) anti-receptor binding domain (RBD) SARS-CoV-2 library based on IgA from Indonesian COVID-19 survivors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"144412"}}